- Tischkau S., Cohen J., Stark J., Gross D., Bottum K. 2007. Time-of-day
affects expression of hippocampal markers for ischemic damage induced
by global ischemia. Exp. Neurology. 208: 314-322.
- Bottum K, Poon E., Comiskey M., Haley B. and Tischkau S.A. 2008. Suprachiasmatic
Nucleus Neurons Display Endogenous Resistance to Excitotoxicity. Neurotox
Res. In revision.
- Wagle R.K., Ede K., Craig J., and Bottum K. 2004. An ethical dilemma:
when the family wants the withdrawal of care. J Psychiatr. Pract.
10(5): 334-6.
- Swartz C.M., Bottum K.M., and Salazar L.S. Jr. 2002. Suppression of
catatonia-like symptoms by lorazepam in nonconvulsive status epilepticus
without seizure termination. Am. J. Geriatr. Psychiatry. 10 (3):
348-350.
- Bottum K. and Jonas A. 1995. Cholesterol transfer from low density
lipoproteins to reconstituted high density lipoproteins is determined
by the properties and concentrations of both particles. Biochemistry.
34: 7264-7270.
- Jonas A., Bottum K., Theret N., Duchateau P., and Castro G. 1994.
Transfer of cholesterol from Ob1771 cells or LDL to reconstituted, defined
high density lipoproteins. J. Lipid Res. 35: 860-870.
- Jonas A., Bottum K., and Kezdy K. 1991. Transformations of reconstituted
high density lipoprotein subclasses as a function of temperature or
LDL concentration. Biochim. Biophys. Acta. 1085: 71-76.
- Karmarkar SW, Bottum KM, Krager SL, Tischkau SA. ERK/MAPK is essential for endogenous neuroprotection in SCN2.2 cells. PLoS One 2011; 6(8) e23493.
- Wang C, Xu C, Krager SL, Bottum KM, Liao DF, Tischkau SA. Aryl Hydrocarbon Receptor Deficiency Enhances Insulin Sensitivity and Reduces PPAR-α Pathway Activity in Mice. Environ Health Perspect 2011, Aug 17.
- Karmarkar SW, Bottum KM, Tischkau SA. Considerations for the use of anesthetics in neurotoxicity studies. Comp Med 2010 Aug; 60(4): 256-62. Review.
- Bottum K, Poon E, Haley B., Karmarkar S., and Tischkau S. Suprachiasmatic nucleus neurons display endogenous resistance to excitotoxicity. Exp Bio Med 2010 Feb; 235(2):237-46.
|